JPH07145033A - Cosmetic for prevention of dermal aging - Google Patents
Cosmetic for prevention of dermal agingInfo
- Publication number
- JPH07145033A JPH07145033A JP4327433A JP32743392A JPH07145033A JP H07145033 A JPH07145033 A JP H07145033A JP 4327433 A JP4327433 A JP 4327433A JP 32743392 A JP32743392 A JP 32743392A JP H07145033 A JPH07145033 A JP H07145033A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- effect
- extract
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、化粧料に関し、更に詳
細には、優れた皮膚老化防止作用、肌荒れ改善作用等を
有する皮膚老化防止用化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition, and more particularly to a cosmetic composition for preventing skin aging, which has excellent effects of preventing skin aging, rough skin, and the like.
【0002】[0002]
【従来の技術】従来、肌荒れ改善や皮膚老化防止のため
に用いられてきた薬効成分としては、アラントイン、ア
ロエ抽出物、人参抽出物、胎盤抽出物、牛血液除蛋白物
及び発酵代謝物等が知られている。しかしながら、これ
らの薬効成分を含む化粧料では、十分な効果を得ること
ができず、より優れた作用を有する化粧料の開発が望ま
れていた。2. Description of the Related Art Conventionally, medicinal ingredients that have been used to improve skin roughness and prevent skin aging include allantoin, aloe extract, ginseng extract, placental extract, bovine blood deproteinate and fermented metabolites. Are known. However, cosmetics containing these medicinal components cannot obtain sufficient effects, and development of cosmetics having more excellent action has been desired.
【0003】一方、エゴマ油は、ω−3系高度不飽和脂
肪酸の一種であるα−リノレン酸を高度に含有してお
り、肌に塗布した場合、潤いを与え、肌のかさつきを防
ぐ効果が知られている。また、このα−リノレン酸は、
体内においてエイコサペンタエン酸やドコサヘキサエン
酸に代謝される。これらのω−3系高度不飽和脂肪酸
は、現在、制ガン効果やアレルギー反応をおこすロイコ
トリエンの産生を減少させ−る効果があることがわか
り、注目を集めている。On the other hand, perilla oil contains a large amount of α-linolenic acid which is a kind of ω-3 polyunsaturated fatty acid, and when applied to the skin, moisturizes and prevents the skin from becoming bulky. Are known. Also, this α-linolenic acid is
It is metabolized in the body to eicosapentaenoic acid and docosahexaenoic acid. These ω-3 polyunsaturated fatty acids are currently attracting attention because they are known to have an anti-cancer effect and an effect of reducing the production of leukotrienes that cause allergic reactions.
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、エゴマ
油の有する上記作用に着目し、これを化粧料、特に肌荒
れ改善作用を有する化粧料に配合することを試みた。し
かし、エゴマ油を単独に配合した場合の肌荒れ改善作用
は十分なものとはいえず、また他の基剤等の影響によ
り、これの本来有する効果が十分に発揮され得ないのが
実情であった。DISCLOSURE OF THE INVENTION The present inventors have focused on the above-mentioned action of sesame oil and attempted to add it to a cosmetic, particularly a cosmetic having a rough skin improving action. However, when the sesame oil is blended alone, the rough skin improving effect cannot be said to be sufficient, and due to the influence of other bases etc., the actual effect of this cannot be sufficiently exerted. It was
【0005】更に、より高い効果を得る目的で、エゴマ
油を高濃度で配合した場合の作用効果にも限界があり、
逆に、これら化合物自体の有する特有の色や臭いの発生
により、配合量や剤型等製品面における制限も生じてく
るといった問題もあった。Further, there is a limit to the action and effect when the perilla oil is blended at a high concentration for the purpose of obtaining a higher effect.
On the contrary, there is also a problem that due to the generation of the unique color and odor of these compounds themselves, there are restrictions on the amount of formulation, formulation, etc. in terms of products.
【0006】[0006]
【課題を解決するための手段】前記実情に鑑み、本発明
者等は、エゴマ油の有する作用を十分に引き出すべく鋭
意研究を行った。そしてその結果、これらと特定の化合
物とを組合せることにより、優れた皮膚老化防止効果、
肌荒れ改善効果が安定且つ相乗的に発揮されることを見
出し本発明を完成した。In view of the above circumstances, the inventors of the present invention have conducted earnest studies to sufficiently bring out the action of perilla oil. And as a result, by combining these with a specific compound, excellent skin aging prevention effect,
The present invention has been completed by finding that the rough skin improving effect is stably and synergistically exhibited.
【0007】すなわち、本発明は、エゴマ油と、センブ
リエキス、カンファ、ニコチン酸もしくはその誘導体、
ニンニクエキス、セファランチン及びトウガラシチンキ
から選ばれる成分の一種または二種以上とを含有する皮
膚老化防止用化粧料を提供するものである。That is, the present invention relates to perilla oil, assemblage extract, camphor, nicotinic acid or its derivative,
A cosmetic for preventing skin aging, which comprises one or more components selected from garlic extract, cepharanthin and capsicum tincture.
【0008】エゴマ油は、シソ科に属するエゴマの果実
より通常用いられる方法により分離、精製されたもので
あり、方法は特に限定されない。また、主成分であるα
−リノレン酸を更に濃縮して含量を高めたものや、ある
いはこれらの他の成分を調合した油脂組成物も含まれ
る。The perilla oil is isolated and purified from the fruits of perilla belonging to the Lamiaceae family by a commonly used method, and the method is not particularly limited. Also, the main component α
-Included are those in which linolenic acid is further concentrated to increase its content, or oil and fat compositions prepared by mixing these other components.
【0009】エゴマ油は、そのまま本発明の化粧料に配
合しても、また、更に水蒸気蒸留、活性炭処理、酸性白
土処理等によって精製したものを利用しても良い。The perilla oil may be blended with the cosmetic of the present invention as it is, or may be refined by steam distillation, activated carbon treatment, acid clay treatment, or the like.
【0010】本発明の化粧料におけるエゴマ油の含有量
は、0.0001〜10重量%(以下単に「%」で示
す)であり、より好ましくは、0.01〜5%である。
含有量が0.0001%未満であると十分な効果が得ら
れないことがあり、また、10%を超えて配合してもそ
れ以上の効果の増大は見られず、かえって着色、臭いの
発生や、剤型によっては沈殿が生じる等、製品面での問
題が生じる場合がある。The content of perilla oil in the cosmetic of the present invention is 0.0001 to 10% by weight (hereinafter simply referred to as "%"), and more preferably 0.01 to 5%.
If the content is less than 0.0001%, a sufficient effect may not be obtained, and even if the content exceeds 10%, no further increase in the effect is observed, and instead, coloring and odor are generated. Also, depending on the dosage form, problems such as precipitation may occur on the product side.
【0011】一方、本発明において他の必須成分である
センブリエキス、カンファ、ニコチン酸もしくはその誘
導体、ニンニクエキス、セファランチン及びトウガラシ
チンキなどの成分(以下、「第二成分」と総称する)
は、いずれも、従来から化粧料に配合されている成分で
ある。これらの第二成分のうち、センブリエキス、カン
ファ、ニンニクエキス、セファランチン及びトウガラシ
チンキは天然物中から抽出により得られる物質である。On the other hand, in the present invention, other essential components such as assembly extract, camphor, nicotinic acid or its derivative, garlic extract, cepharanthin and capsicum tincture (hereinafter collectively referred to as "second component").
Are all components that have been conventionally blended in cosmetics. Among these second components, the assembly extract, camphor, garlic extract, cepharanthin and capsicum tincture are substances obtained by extraction from natural products.
【0012】すなわち、センブリエキスは、センブリ
[Swertia japonicaMakino(G
entia neceae)]の開花期の全草からエタ
ノール、精製水、またはこれらの混液で抽出して得られ
るエキスであり、カンファは、クスノキ[Cinnam
omum camphora Linne(Laura
ceae)]より得られるテルペンケトンである。[0012] That is, the assembly extract is a product of [Sertieria japonica Makino (G
[entia neceae)] is an extract obtained by extracting with ethanol, purified water, or a mixed solution thereof from whole plants in the flowering period, and camphor is camphor [Cinnam
om camphora linne (Laura
ceae)] is a terpene ketone.
【0013】また、ニンニクエキスは、ニンニク(Al
lium scordoplasmL.またはAlli
um sativum L.)の鱗茎から精製水、無水
エタノール、プロピレングリコール、1,3−ブチレン
グリコールまたはこれらの混液にて抽出して得られるエ
キスである。The garlic extract is garlic (Al
ium scodoplasm L. Or Alli
um sativum L. ) Is an extract obtained by extracting the bulb from purified water, absolute ethanol, propylene glycol, 1,3-butylene glycol or a mixture thereof.
【0014】更に、セファランチンは、ツヅラフジ科の
植物タマサキツヅラフジ(Stephaura cep
harantha Hayata)の根より抽出して得
られるものである。更にまた、トウガラシチンキは、ト
ウガラシ[Capsicum annuum Linn
e(Solanaceae)]またはその変種の果実を
エタノールで浸出して得られるチンキ剤である。なお、
いずれの場合も抽出方法、精製処理方法については特に
制約はない。[0014] Further, cepharanthin is a plant belonging to the family Amaranthaceae, Tamasaki tsutsurafuji (Stephaura cep).
Harantha Hayata). Furthermore, capsicum tincture is a capsicum [Capsicum annuum Linn
e (Solanaceae)] or a variety thereof, which is a tincture obtained by leaching with ethanol. In addition,
In either case, there are no particular restrictions on the extraction method and the purification treatment method.
【0015】一方、ニコチン酸及びその誘導体は、ビタ
ミンBの一種であり、牛肝臓または米糠等から抽出して
得られるものでも合成によって得られるものでも良く、
ニコチン酸の他、ニコチン酸アミド、ニコチン酸DL−
α−トコフェロール、ニコチン酸メチル等のニコチン酸
誘導体が例示される。On the other hand, nicotinic acid and its derivatives are a kind of vitamin B, and may be those obtained by extraction from beef liver, rice bran or the like, or those obtained by synthesis,
In addition to nicotinic acid, nicotinic acid amide, nicotinic acid DL-
Examples include nicotinic acid derivatives such as α-tocopherol and methyl nicotinate.
【0016】これら第二成分の本発明化粧料中の含有量
は、一般には0.0001〜5%、好ましくは0.00
1〜3%である。これら成分の含有量が0.0001%
より少ない場合は、十分な効果が得られないことがあ
り、また、5%を超えて配合しても効果がほぼ一定とな
り、その増大は見られない。The content of these second components in the cosmetic of the present invention is generally 0.0001 to 5%, preferably 0.001.
1 to 3%. The content of these components is 0.0001%
If it is less than the above range, a sufficient effect may not be obtained, and even if the content exceeds 5%, the effect becomes almost constant, and the increase is not observed.
【0017】更に、本発明の化粧料には、本発明の効果
を損なわない範囲で、前記必須成分の他に、通常の化粧
料に用いられる水性成分、粉体、界面活性剤、油剤、保
湿剤、アルコール類、pH調整剤、防腐剤、色素、酸化
防止剤、紫外線吸収剤、増粘剤、香料、美容成分等を必
要に応じて適宜配合することができる。Further, in the cosmetic of the present invention, in addition to the above-mentioned essential components, an aqueous component, a powder, a surfactant, an oil agent, a moisturizing agent used in ordinary cosmetics, in the range not impairing the effects of the present invention. Agents, alcohols, pH adjusters, antiseptics, pigments, antioxidants, ultraviolet absorbers, thickeners, fragrances, cosmetic ingredients and the like can be appropriately added as necessary.
【0018】本発明の皮膚老化防止化粧料は、必須成分
である前述のエゴマ油と、センブリエキス、カンファ、
ニコチン酸もしくはその誘導体、ニンニクエキス、セフ
ァランチン及びトウガラシチンキから選ばれる成分の一
種または二種以上とを配合し、常法に従って製造するこ
とができ、乳液、クリーム、化粧水、美容液、クレンジ
ング、パック、洗浄料、ファンデーション等として適用
することができる。The skin anti-aging cosmetic composition of the present invention contains the above-mentioned sesame oil which is an essential component, the assembly extract, camphor,
Nicotinic acid or a derivative thereof, garlic extract, cepharanthine and one or more components selected from capsicum tincture can be blended and produced according to a conventional method, emulsion, cream, lotion, beauty essence, cleansing, pack. It can be applied as a cleaning agent, foundation, etc.
【0019】[0019]
【実施例】次に、実施例を挙げ本発明を更に詳しく説明
するが、本発明はこれらになんら制約されるものではな
い。EXAMPLES Next, the present invention will be described in more detail by way of examples, which should not be construed as limiting the invention thereto.
【0020】実施例1〜4 クリーム 下記表1に示す組成のクリームを製造し、肌荒れ改善効
果を調べた。この結果も表1に示す。なお、クリームの
製法及び評価方法は次のとおりである。Examples 1 to 4 Creams Creams having the compositions shown in Table 1 below were produced, and the effect of improving rough skin was examined. The results are also shown in Table 1. The cream production method and evaluation method are as follows.
【0021】[0021]
【表1】 [Table 1]
【0022】(製法) A.成分(8)、(10)〜(14)を加熱混合し、7
0℃に保つ。 B.成分(1)〜(7)及び(9)を加熱混合し、70
℃に保つ。 C.上記Bを先のAに加えて混合し、均一に乳化する。 D.上記C冷却後、(15)を加え、均一に混合してク
リームを得た。(Production Method) A. The components (8) and (10) to (14) are heated and mixed, and
Keep at 0 ° C. B. The components (1) to (7) and (9) are heated and mixed to obtain 70
Keep at ℃. C. The above B is added to the above A, mixed and uniformly emulsified. D. After cooling the above C, (15) was added and uniformly mixed to obtain a cream.
【0023】(評価方法)健常な男性135名をパネル
とし、1群15名として、顔面半分に実施例1〜4また
は比較例1〜5のクリームを、他の反面に比較例6のク
リームを、それぞれ1日1回、2週間塗布した。2週間
後、顔面皮膚レプリカを採取し、下記に示す基準により
評価した。得られた実施例1〜4、比較例1〜5のクリ
ーム塗布部位のレプリカのスコアから比較例6のクリー
ム塗布部位のレプリカのスコアを引いた値を肌荒れ改善
度とした。なお、パネルには、試験開始前のスコアが1
または2の男性を選んだ。(Evaluation method) 135 healthy men were used as a panel, and 15 people per group, the creams of Examples 1 to 4 or Comparative Examples 1 to 5 were applied to one half of the face, and the cream of Comparative Example 6 was applied to the other face. , Once a day for 2 weeks. Two weeks later, a facial skin replica was collected and evaluated according to the criteria shown below. The value obtained by subtracting the score of the replica of the cream applied site of Comparative Example 6 from the obtained score of the replica of the cream applied site of Examples 1 to 4 and Comparative Examples 1 to 5 was taken as the degree of improvement in skin roughness. In addition, the score before the start of the test is 1 on the panel
Or I chose 2 men.
【0024】 肌状態スコア: スコア 状態 1 肌の皮溝が不鮮明であり、角質のはがれが認められる。 2 肌の皮溝がやや不鮮明であるかまたは一方向性が強い。 3 肌の皮溝は認められるが、浅いかまたは一方向性がやや強い。 4 肌の皮溝が認められるかまたはやや網目状である。 5 肌の皮溝がはっきり認められるかまたはきれいな網目状である。Skin condition score: Score condition 1 The skin groove of the skin is unclear and peeling of the keratin is observed. 2 The skin groove on the skin is slightly blurred or unidirectional. 3 Skin groove is observed, but it is shallow or slightly unidirectional. 4 Skin crevices are observed or are slightly mesh-like. 5 Skin groove is clearly visible or has a clean mesh.
【0025】以上の結果から、エゴマ油と第二成分とを
配合した本発明化粧料は、エゴマ油または第二成分を単
独で配合した場合に比べて、顕著な肌荒れ改善効果を奏
することが明らかである。From the above results, it is clear that the cosmetic of the present invention in which the sesame oil and the second component are blended has a remarkable effect of improving rough skin as compared with the case where the sesame oil or the second component is blended alone. Is.
【0026】実施例5〜6 クリーム 表2に示す組成及び下記製法でクリームを調製し、下記
方法でその皮膚老化防止作用を調べた。Examples 5 to 6 Cream Creams were prepared according to the composition shown in Table 2 and the following production method, and their anti-aging effect on skin was examined by the following method.
【0027】[0027]
【表2】 [Table 2]
【0028】(製法) A.成分(9)〜(11)及び(13)を加熱混合し、
70℃に保つ。 B.成分(1)〜(8)を加熱混合し、70℃に保つ。 C.上記Bを先のAに加えて混合し、均一に乳化する。 D.上記Cを冷却後、成分(12)を加え、均一に混合
してクリームを得た。(Production Method) A. The components (9) to (11) and (13) are heated and mixed,
Keep at 70 ° C. B. The components (1) to (8) are mixed by heating and kept at 70 ° C. C. The above B is added to the above A, mixed and uniformly emulsified. D. After cooling the above C, the component (12) was added and uniformly mixed to obtain a cream.
【0029】(評価方法)26〜52才の女性15名を
パネルとし、毎日朝と夜の2回、12週間にわたって洗
顔後に被験クリームの適量を顔面に塗布した。塗布によ
る美肌効果及び皮膚老化防止効果を下記の基準によって
評価した。(Evaluation Method) Fifteen women aged 26 to 52 were used as a panel, and an appropriate amount of the test cream was applied to the face after washing the face twice a day every morning and night for 12 weeks. The effect of applying beautiful skin and the effect of preventing skin aging were evaluated according to the following criteria.
【0030】美肌効果: 評価 内容 有効 肌のくすみが見立たなくなった。 やや有効 肌のくすみがやや目立たなくなった。 無効 使用前と変化なし。Skin-Beauty Effect: Evaluation Content Effective Dullness of the skin became inconspicuous. Somewhat effective The dullness of the skin has become a little less noticeable. Disabled No change from before use.
【0031】皮膚老化防止効果: 評価 内容 有効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無効 使用前と変化なし。Skin Aging Preventive Effect: Evaluation Content Effective The skin's suppleness and gloss were improved. Slightly effective Skin tone and gloss were slightly improved. Disabled No change from before use.
【0032】(結果)結果を表3に示す。(Results) The results are shown in Table 3.
【0033】[0033]
【表3】 [Table 3]
【0034】表3の結果、明きらかな如く、実施例5及
び6のクリームは肌の「つや」、「はり」の喪失・「く
すみ」等の発生の防止、改善に有効であり、皮膚老化防
止効果が認められた。As is clear from the results shown in Table 3, the creams of Examples 5 and 6 are effective in preventing and improving the loss of "gloss", "beams" and "dullness" of the skin, and aging of the skin. The preventive effect was recognized.
【0035】 実施例7 化粧水 (処方) (重量%) (1)ポリオキシエチレン硬化ヒマシ油(60E.O.) 1.0 (2)エチルアルコール 10.0 (3)防腐剤 0.1 (4)香料 適量 (5)エゴマ油 1.0 (6)センブリエキス 0.5 (7)ソルビトール(70%水溶液) 3.0 (8)ピロリドンカルボン酸ナトリウム 3.0 (9)精製水 残量Example 7 Lotion (Formulation) (wt%) (1) Polyoxyethylene hydrogenated castor oil (60 EO) 1.0 (2) Ethyl alcohol 10.0 (3) Preservative 0.1 ( 4) Perfume proper amount (5) Perilla oil 1.0 (6) Assemblage extract 0.5 (7) Sorbitol (70% aqueous solution) 3.0 (8) Sodium pyrrolidonecarboxylate 3.0 (9) Purified water Remaining amount
【0036】(製法) A.成分(1)〜(5)を加熱、混合溶解する。 B.成分(6)〜(9)を加熱、混合溶解する。 C.上記AとBを混合して均一とし、化粧水を得た。(Production Method) A. The components (1) to (5) are heated and mixed to dissolve. B. The components (6) to (9) are heated and mixed to dissolve. C. The above A and B were mixed and made uniform to obtain a lotion.
【0037】 実施例8 乳液 (処方) (重量%) (1)ポリオキシエチレンソルビタンモノステアレート 1.0 (10E.O.) (2)ポリオキシエチレンソルビットテトラオレエート 0.5 (60E.O.) (3)グリセリンモノステアレート 1.0 (4)ステアリン酸 0.5 (5)ベヘニルアルコール 0.5 (6)精製アボガド油 4.0 (7)トリ2−エチルヘキサン酸グリセリン 4.0 (8)防腐剤 0.1 (9)エゴマ油 1.0 (10)ウィッチヘーゼルエキス 0.1 (11)キサンタンガム(2%水溶液) 7.0 (12)1,3−ブチレングリコール 5.0 (13)カンファ 1.0 (14)セファランチン 1.0 (15)精製水 残量 (16)香料 適量Example 8 Emulsion (formulation) (wt%) (1) Polyoxyethylene sorbitan monostearate 1.0 (10 EO) (2) Polyoxyethylene sorbit tetraoleate 0.5 (60 EO) (3) Glycerin monostearate 1.0 (4) Stearic acid 0.5 (5) Behenyl alcohol 0.5 (6) Refined avocado oil 4.0 (7) Glycerin tri-2-ethylhexanoate 4.0 ( 8) Preservative 0.1 (9) Perilla oil 1.0 (10) Witch hazel extract 0.1 (11) Xanthan gum (2% aqueous solution) 7.0 (12) 1,3-butylene glycol 5.0 (13) ) Camphor 1.0 (14) Cepharanthin 1.0 (15) Purified water Remaining amount (16) Perfume proper amount
【0038】(製法) A.成分(10)〜(15)を加熱混合して、70℃に
保つ。 B.成分(1)〜(9)を加熱混合し、70℃に保つ。 C.上記Bを先のAに加え混合し、均一に乳化する。 D.上記Cを冷却後、(16)を加え、均一に混合して
乳液を得た。(Production Method) A. The components (10) to (15) are mixed by heating and kept at 70 ° C. B. The components (1) to (9) are mixed by heating and kept at 70 ° C. C. The above B is added to the above A, mixed and uniformly emulsified. D. After cooling the above C, (16) was added and uniformly mixed to obtain an emulsion.
【0039】 実施例9 軟膏 (処方) (重量%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)トリエタノールアミン 2.0 (4)グリセリン 5.0 (5)エゴマ油 2.0 (6)ニンニクエキス 1.0 (7)精製水 残量Example 9 Ointment (formulation) (% by weight) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Perilla oil 2.0 (6) Garlic extract 1.0 (7) Purified water Remaining amount
【0040】(製法) A.成分(3)〜(4)及び(7)の一部を加熱混合
し、75℃に保つ。 B.成分(1)〜(2)及び(5)を加熱混合し、75
℃に保つ。 C.上記Aを先のBに徐々に加える。 D.上記Cを冷却しながら(7)の残部で溶解した
(6)を加え、軟膏を得た。(Production Method) A. A part of the components (3) to (4) and (7) is mixed by heating and kept at 75 ° C. B. The components (1) to (2) and (5) are heated and mixed, and 75
Keep at ℃. C. Gradually add A above to B above. D. While cooling the above C, (6) dissolved in the rest of (7) was added to obtain an ointment.
【0041】[0041]
【発明の効果】以上詳述した如く、本発明により、安定
で優れた皮膚老化防止効果、肌荒れ改善効果を有する化
粧料が得られる。INDUSTRIAL APPLICABILITY As described in detail above, according to the present invention, a cosmetic having a stable and excellent effect of preventing skin aging and improving rough skin can be obtained.
Claims (1)
ァ、ニコチン酸もしくはその誘導体、ニンニクエキス、
セファランチン及びトウガラシチンキから選ばれる成分
の一種または二種以上とを含有する皮膚老化防止用化粧
料。1. Sesame oil, assemblage extract, camphor, nicotinic acid or its derivative, garlic extract,
A cosmetic for preventing skin aging containing one or more components selected from cepharanthin and capsicum tincture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32743392A JP3170700B2 (en) | 1992-11-12 | 1992-11-12 | Cosmetic for preventing skin aging |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32743392A JP3170700B2 (en) | 1992-11-12 | 1992-11-12 | Cosmetic for preventing skin aging |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07145033A true JPH07145033A (en) | 1995-06-06 |
JP3170700B2 JP3170700B2 (en) | 2001-05-28 |
Family
ID=18199117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32743392A Expired - Fee Related JP3170700B2 (en) | 1992-11-12 | 1992-11-12 | Cosmetic for preventing skin aging |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3170700B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508281A (en) * | 1996-04-23 | 1999-07-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | How to adjust the appearance of skin with Vitamin B compounds |
JP2002212026A (en) * | 2001-01-18 | 2002-07-31 | Oriza Yuka Kk | Skin care preparation for beautifying skin |
KR100372360B1 (en) * | 2000-09-06 | 2003-02-19 | 로제화장품 주식회사 | Cosmetic compositions containing garlic and Acanthopanax extracts |
EP1262169A3 (en) * | 2001-05-29 | 2004-05-06 | L'oreal | Skin anti-ageing composition |
JP2008231055A (en) * | 2007-03-22 | 2008-10-02 | Noevir Co Ltd | Skin care preparation for external use, and food and drink |
US20170020796A1 (en) * | 2014-03-10 | 2017-01-26 | Lucas Meyer Cosmetics | Cosmetic uses of swertiamarin |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102052511B1 (en) * | 2019-03-12 | 2019-12-05 | 임수복 | Perilla oil and Method for manufacturing the same |
-
1992
- 1992-11-12 JP JP32743392A patent/JP3170700B2/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508281A (en) * | 1996-04-23 | 1999-07-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | How to adjust the appearance of skin with Vitamin B compounds |
KR100372360B1 (en) * | 2000-09-06 | 2003-02-19 | 로제화장품 주식회사 | Cosmetic compositions containing garlic and Acanthopanax extracts |
JP2002212026A (en) * | 2001-01-18 | 2002-07-31 | Oriza Yuka Kk | Skin care preparation for beautifying skin |
EP1262169A3 (en) * | 2001-05-29 | 2004-05-06 | L'oreal | Skin anti-ageing composition |
JP2008231055A (en) * | 2007-03-22 | 2008-10-02 | Noevir Co Ltd | Skin care preparation for external use, and food and drink |
US20170020796A1 (en) * | 2014-03-10 | 2017-01-26 | Lucas Meyer Cosmetics | Cosmetic uses of swertiamarin |
US11285093B2 (en) * | 2014-03-10 | 2022-03-29 | International Flavors & Fragrances Inc. | Cosmetic uses of swertiamarin |
Also Published As
Publication number | Publication date |
---|---|
JP3170700B2 (en) | 2001-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3499616B2 (en) | Application to hydroxytyrosol, melanin production inhibitor or lipid peroxide production inhibitor | |
JP2903412B2 (en) | Cosmetics | |
JPH09241146A (en) | Skin external agent | |
CN116209425A (en) | Composition for preventing alopecia and promoting hair growth | |
JPH07145033A (en) | Cosmetic for prevention of dermal aging | |
JP4460420B2 (en) | Collagen production promoter | |
JP3197938B2 (en) | Cosmetic for preventing skin aging | |
WO1993021895A1 (en) | Scalp care product composition | |
JPH10279428A (en) | Cosmetic | |
JP2001131031A (en) | Composition for scalp and hair | |
JP2000159653A (en) | Preparation for external use for skin | |
JP3382148B2 (en) | External preparation for head | |
JPH11302149A (en) | Melanin production inhibitor and external preparation for skin containing the same | |
JP3382149B2 (en) | External preparation for head | |
JPH08119829A (en) | External medicine for skin | |
JP2811479B2 (en) | Hair restoration | |
JPH1180016A (en) | Preparation for external use for skin for prevention of aging | |
JPH10273424A (en) | Cosmetic for hair | |
JPH04334308A (en) | Skin cosmetic | |
JP2003267851A (en) | Skin care preparation | |
WO1995019758A1 (en) | Hair-care composition | |
JP2003342156A (en) | External preparation for skin for prevention of aging | |
JP4473439B2 (en) | Whitening agent | |
JP3337845B2 (en) | Hair restoration composition | |
JP4245862B2 (en) | Topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |